M&A Deal Summary |
|
---|---|
Date | 2006-04-21 |
Target | Guidant |
Sector | Life Science |
Buyer(s) | Boston Scientific |
Deal Type | Add-on Acquisition |
Deal Value | 24.6B USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1979 |
Sector | Medical Products |
Employees | 48,000 |
Revenue | 14.2B USD (2023) |
Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 10 of 65 |
Sector (Life Science) | 2 of 6 |
Type (Add-on Acquisition) | 10 of 50 |
State (Indiana) | 1 of 1 |
Country (United States) | 9 of 50 |
Year (2006) | 1 of 1 |
Size (of disclosed) | 1 of 34 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2005-04-18 |
TriVascular
Santa Rosa, California, United States TriVascular, Inc. is a medical device company that design and manufacture endovascular aortic repair (EVAR). TriVascular’s initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2007-01-05 |
EndoTex Interventional Systems
Cupertino, California, United States EndoTex Interventional Systems, Inc. is a medical device company provides carotid artery stent. |
Buy | - |